| Serotonin receptor antagonists for highly emetogenic chemotherapy in adults. | |
| | |
MedLine Citation:
|
PMID: 20091591 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Serotonin receptor antagonists (5-HT(3) RAs) are used to control chemotherapy-induced emesis. Although they have the same general mechanism of action (blockade of serotonin receptors), they have different chemical structures and may have different effects. OBJECTIVES: To compare efficacy of different serotonin receptor antagonists (5-HT(3) RAs) in the control of acute and delayed emesis induced by highly emetogenic chemotherapy. SEARCH STRATEGY: We searched CENTRAL, the Specialised Register of the Cochrane PaPaS Group, PubMed, EMBASE, and LILACS databases. Our most recent search was in March 2009. SELECTION CRITERIA: Randomised trials comparing 5-HT(3) RAs in an adult cancer population. DATA COLLECTION AND ANALYSIS: We extracted information from the included studies on the control of acute and delayed nausea and vomiting, either as a single or a combined outcome. Where appropriate, we combined the results of similar trials. We carried out sensitivity and subgroup analyses to test the robustness of our findings. MAIN RESULTS: We included 16 randomised trials (7808 participants). Nine of the trials compared granisetron versus ondansetron. No other drug comparison was studied in more than one trial. The meta-analyses of the granisetron versus ondansetron trials found similar results for the two drugs on acute vomiting (eight trials, 4256 participants, odds ratio (OR) 0.89; 95% CI 0.78 to 1.02), acute nausea (seven trials, 4160 participants, OR 0.97; 95% CI 0.85 to 1.10), delayed vomiting (three trials, 1119 participants, OR 1.00; 95% CI 0.74 to 1.34) and delayed nausea (two trials, 1024 participants, OR 0.96; 95% CI 0.75 to 1.24). Granisetron and ondansetron showed similar effects on headache and diarrhoea, with the possible exception of less constipation associated with ondansetron.One study of 1114 participants comparing palonosetron plus dexamethasone versus granisetron plus dexamethasone showed superiority of palonosetron in controlling delayed vomiting (OR 1.45; 95% CI 1.14 to 1.85) and delayed nausea (OR 1.63; 95% CI 1.27 to 2.10). Complete response for delayed nausea and vomiting was also in favour of the combination palonosetron and dexamethasone (OR 1.63; 95% CI 1.29 to 2.07). AUTHORS' CONCLUSIONS: Ondansetron and granisetron appear to be equivalent drugs for the prevention of acute and delayed emesis following the use of highly emetogenic chemotherapy.According to one single trial the combination of palonosetron and dexamethasone was superior to granisetron and dexamethasone in controlling delayed emesis. However, more evidence is needed before palonosetron could become the candidate 5-HT(3) RA for the control of delayed emesis induced by highly emetogenic chemotherapy. |
| | |
Authors:
|
Atto Billio; Enrico Morello; Mike J Clarke |
Publication Detail:
|
Type: Journal Article; Meta-Analysis; Review Date: 2010-01-20 |
Journal Detail:
|
Title: Cochrane database of systematic reviews (Online) Volume: - ISSN: 1469-493X ISO Abbreviation: Cochrane Database Syst Rev Publication Date: 2010 |
Date Detail:
|
Created Date: 2010-01-21 Completed Date: 2010-04-16 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100909747 Medline TA: Cochrane Database Syst Rev Country: England |
Other Details:
|
Languages: eng Pagination: CD006272 Citation Subset: IM |
Affiliation:
|
Department of Haematology and Bone Marrow Transplantation, Central Hospital S, Maurizio, Bolzano, Italy, 39100. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Dexamethasone / adverse effects, therapeutic use Granisetron / adverse effects, therapeutic use Humans Isoquinolines / adverse effects, therapeutic use Nausea / chemically induced, drug therapy* Ondansetron / adverse effects, therapeutic use Quinuclidines / adverse effects, therapeutic use Randomized Controlled Trials as Topic Receptors, Serotonin, 5-HT3 / antagonists & inhibitors* Vomiting / chemically induced, drug therapy* |
| Chemical | |
Reg. No./Substance:
|
0/Isoquinolines; 0/Quinuclidines; 0/Receptors, Serotonin, 5-HT3; 109889-09-0/Granisetron; 135729-61-2/palonosetron; 50-02-2/Dexamethasone; 99614-02-5/Ondansetron |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Primary surgery versus primary radiation therapy with or without chemotherapy for early adenocarcino...
Next Document: Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived ...